This significant expansion enhances its interdisciplinary research and development capabilities at the Blagnac and Beauzelle sites
Lallemand announces the inauguration of its new laboratories in France, increasing its capacity by over 800 square meters. This significant expansion enhances its interdisciplinary research and development capabilities at the Blagnac and Beauzelle sites. The over 1.7 million euros investment will enable the seventy scientists and technicians working at these two sites to continue their involvement in ambitious research and development programs.
This expansion and acquiring new, state-of-the-art equipment will enable Lallemand to strengthen its bioprocess innovation cluster and accelerate the development of next-generation strains. The research departments of the following business units: Specialty Cultures, Oenology, Animal Health, Human Health, and Plant Care, will benefit from these new spaces and technologies, expanding the possibilities offered by the microorganisms they are studying.
Sylvie Binda, Vice-President of Research and Development at Lallemand Health Solutions, stated: “Strengthening our fermentation process capabilities is a strategic priority for Lallemand. This commitment is reflected in the creation of laboratories of excellence, the training of teams, and the implementation of collaborative research programs aimed at leveraging complementary expertise to optimise the impact of our initiatives.”
